Related Experiment Video For Cancer
Updated: Sep 14, 2025

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
Primary and metastatic cellular landscapes in human pancreatic cancer
Nina G Steele1,2, Veerin R Sirihorachai3, Ahmed M Elhossiny4
1Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a complex tumor microenvironment (TME). We utilized single cell RNA sequencing to compare the TMEs of metastatic sites and primary tumors. We detected increased prevalence of exhausted CD8+ T cells in metastases, as well as the enrichment of complement pathway encoding genes in immunosuppressive tumor-associated macrophages, consistent with profound immunosuppression in metastatic disease. In cancer-associated fibroblasts, we identified a unique upregulation of metabolic genes, including UPP1, in metastasis. In cancer cells, we uncovered a specific gene signature upregulated in liver metastases; this signature was present in a proportion of primary tumors in the TCGA dataset, where it correlated with worse survival. Overall, our analysis of primary and metastatic PDAC defines a "high-risk" gene signature, metabolic reprogramming, and increased immune suppression in metastasis.

